- Home
- CMPX vs SJT Comparison
CMPX vs SJT Comparison
Compare CMPX & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SJT
- Stock Information
- Founded
- CMPX 2014
- SJT 1980
- Country
- CMPX United States
- SJT United States
- Employees
- CMPX N/A
- SJT N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SJT Oil & Gas Production
- Sector
- CMPX Health Care
- SJT Energy
- Exchange
- CMPX Nasdaq
- SJT Nasdaq
- Market Cap
- CMPX 206.3M
- SJT 181.8M
- IPO Year
- CMPX N/A
- SJT N/A
- Fundamental
- Price
- CMPX $1.46
- SJT $3.79
- Analyst Decision
- CMPX Strong Buy
- SJT
- Analyst Count
- CMPX 4
- SJT 0
- Target Price
- CMPX $13.75
- SJT N/A
- AVG Volume (30 Days)
- CMPX 422.2K
- SJT 233.0K
- Earning Date
- CMPX 11-12-2024
- SJT 01-03-2025
- Dividend Yield
- CMPX N/A
- SJT 3.19%
- EPS Growth
- CMPX N/A
- SJT N/A
- EPS
- CMPX N/A
- SJT 0.19
- Revenue
- CMPX $850,000.00
- SJT $11,031,594.00
- Revenue This Year
- CMPX N/A
- SJT N/A
- Revenue Next Year
- CMPX $610.48
- SJT N/A
- P/E Ratio
- CMPX N/A
- SJT $20.31
- Revenue Growth
- CMPX N/A
- SJT N/A
- 52 Week Low
- CMPX $0.77
- SJT $3.21
- 52 Week High
- CMPX $2.34
- SJT $5.81
- Technical
- Relative Strength Index (RSI)
- CMPX 45.22
- SJT 41.64
- Support Level
- CMPX $1.33
- SJT $3.80
- Resistance Level
- CMPX $1.55
- SJT $4.31
- Average True Range (ATR)
- CMPX 0.12
- SJT 0.17
- MACD
- CMPX -0.00
- SJT -0.04
- Stochastic Oscillator
- CMPX 27.66
- SJT 8.47
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.